We note that mutations in beta-catenin, FBXW11’s substrate, have also been observed in colon cancer, where they affect Ser and Thr residues that are essential for the phosphorylation-dependent degradation of beta-catenin (67). This evidence concerns the gene CTNNB1 and colonic neoplasm.